Status:
COMPLETED
Colorectal Cancer Awareness, Research, Education and Screening (CARES)
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Conditions:
Colorectal Cancer
Eligibility:
All Genders
50-75 years
Phase:
NA
Brief Summary
There are two parts to this study: (1) an information gathering phase leading to the development of new educational materials; and (2) a study to test the newly developed material. The information gat...
Detailed Description
Federally qualified health centers (FQHCs) and other community health clinics (CHCs) provide comprehensive primary health care for underserved patients. Recently, high-sensitivity and high-specificity...
Eligibility Criteria
Inclusion
- Racially-ethnically diverse adult men and women
- Average risk individuals who have no personal diagnosis, or presumptive symptoms of colorectal cancer (CRC), or are not at high risk
- Self-report as not current on screening
- Provide at least two forms of contact information and contact information of a relative (not living with respondent) to facilitate follow-up contacts
- Are able to speak, read and write English because the instruments and CARES intervention are available only in English at this time. We recognize that interventions are needed for non-English speaking populations, therefore, once we find promise in the English language CARES intervention materials, we will move forward with conducting other studies that involve translation of measures and cultural adaptation of the CARES intervention materials into Spanish or Haitian Creole.
Exclusion
- Individuals who have participated in a CRCS research study in the past 1 year will not be eligible for this study.
- Recent screening criteria relates to not having had I-FOBT within the previous year, flex sig within the previous 5 years, a double-contrast barium enema (DCBE) x-ray with the previous 5 years, or a colonoscopy within the previous 10 years.
- Within the recruitment and intervention frame, high risk individuals (due to strong family history, ulcerative colitis, polyposis syndromes) are excluded because they may be eligible for CRC screening before age 50, and the preferred screening option is certainly colonoscopy which is beyond the primary focus of the current study.
Key Trial Info
Start Date :
February 11 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 9 2022
Estimated Enrollment :
514 Patients enrolled
Trial Details
Trial ID
NCT01804179
Start Date
February 11 2011
End Date
September 9 2022
Last Update
September 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States, 33612